| Literature DB >> 24804262 |
Sadan Yavuz1, Murat Kasap2, Gurler Akpinar3, Ersan Ozbudak1, Dilek Ural4, Turan Berki1.
Abstract
Pericardial fluid (PF) is often considered to be reflection of the serum by which information regarding the physiological status of the heart can be obtained. Some local and systemic disorders may perturb the balance between synthesis and discharge of PF and may cause its aberrant accumulation in the pericardial cavity as pericardial effusion (PE). PE may then lead to an increased intrapericardial pressure from which the heart function is undesirably affected. For some cases, the causes for the perturbance of fluid balance are well understood, but in some other cases, they are not apparent. It may, thus, be helpful to understand the molecular mechanisms behind this troublesome condition to elucidate a clinical approach for therapeutic uses. In this study, protein profiles of PEs from idiopathic pericarditis patients were analyzed. Control samples from patients undergoing elective cardiac surgery (ECS) were included for comparison. In addition to high abundant serum-originated proteins that may not hold significance for understanding the molecular mechanisms behind this disease, omentin-1 was identified and its level was higher for more than two-fold in PE of IP patients. Increased levels of omentin-1 in PE may open a way for understanding the molecular mechanisms behind idiopathic pericarditis (IP).Entities:
Mesh:
Substances:
Year: 2014 PMID: 24804262 PMCID: PMC3996951 DOI: 10.1155/2014/942718
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Demographic features and biochemical test results for the RIP and ECS patients.
| Demographic features | Pericardial effusion | Elected cardiac surgery | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 1 | 2 | 3 | 4 | 5 | |
| Sex (male/female) | F | F | M | M | F | M | F | M | M | F | F | M |
| Age (year) | 58 | 45 | 63 | 70 | 59 | 42 | 69 | 41 | 63 | 53 | 65 | 72 |
| Hypertension (+/−) |
|
|
|
|
|
|
|
|
|
|
|
|
| Diabetes mellitus (+/−) |
|
|
|
|
|
|
|
|
|
|
|
|
| Myocardial infarction (+/−) |
|
|
|
|
|
|
|
|
|
|
|
|
| Ejection fraction (%) | 66 | 60 | 65 | 68 | 88 | 67 | 56 | 45 | 40 | 30 | 60 | 78 |
|
| ||||||||||||
| Biochemical test results | ||||||||||||
| BUN (mg/dL) | 13.1 | 10 | 15 | 9 | 14 | 18 | 13 | 13 | 17 | 20 | 16.5 | 21 |
| Creatinine (mg/dL) | 0.65 | 0.66 | 0.5 | 0.8 | 0.9 | 0.71 | 0.7 | 0.8 | 0.9 | 0.6 | 0.79 | 1.02 |
| GOT (U/L) | 18 | 11 | 28 | 16 | 17 | 25 | 60 | 18 | 53 | 23 | 28 | 24 |
| GPT (U/L) | 16 | 15 | 18 | 11 | 12 | 38 | 14 | 22 | 37 | 21 | 18 | 18 |
| Albumin (g/dL) | 4.41 | 3.9 | 3.1 | 3.42 | 3.4 | 3.45 | 3.6 | 4.4 | 4 | 3.5 | 3.6 | 3.9 |
| LDH (U/L) | 216 | 215 | 251 | 205 | 230 | 169 | 334 | 237 | 210 | 183 | 178 | 192 |
| TP (g/dL) | 7.26 | 7.1 | 6.6 | 6.5 | 5.9 | 6.3 | 8.2 | 7.1 | 7.3 | 6.8 | 7 | 7.5 |
| LDH (PE) (U/L) | 95 | 130 | 141 | 138 | 167 | 102 | 147 | |||||
| TP (PE) (g/dL) | 2.2 | 5.1 | 3.6 | 3.4 | 2.8 | 3.2 | 3.6 | |||||
| CRP (mg/L) | 0.231 | 0.293 | 0.6 | 0.23 | 2.03 | 1.7 | 0.6 | 0.3 | 0.2 | 0.76 | 1.26 | 0.29 |
| ADA (u/L) | 9.20 | 22 | 15 | 24 | 38 | 18 | 23 | |||||
| TSH (Uıu/mL) | 0.994 | 0.665 | 1.203 | 1.27 | 0.22 | 1.69 | 4.4 | 0.8 | 0.768 | 0.63 | 0.71 | 1.11 |
Figure 1(a) SDS-PAGE analysis of MicroRotofor fractions of a PE after 3 hr. of focusing at 1 W. Notice that majority of the albumin was collected in fraction 3. The shadowy darkness at an increasing pattern was due to ampholyte (pH 3–10) that was added to the protein mixture at a concentration of 2% before focusing. (b) 2D analysis of MicroRotofor fractions. Fraction 4 was the only fraction that contained detectable level of omentin-1. (c) Positions of the protein spots that were identified in fraction 4. Despite the extensive prefractionation, high abundant proteins were still dominating the gel.
Tryptic peptides of omentin-1 identified by MALDI-TOF/TOF analysis.
| Calculated mass | Observed mass | ±Da | ±ppm | Start sequence | End sequence | Sequence |
|---|---|---|---|---|---|---|
| 2059.9792 | 2059.8721 | −0.1071 | −52 | 43 | 59 | EIKDECPSAFDGLYFLR |
| 1292.5906 | 1292.6897 | 0.0991 | 77 | 219 | 229 | TASYYSPYGQR |
| 1201.6 | 1201.6957 | 0.0957 | 80 | 230 | 239 | EFTAGFVQFR |
| 1424.7783 | 1424.8894 | 0.1111 | 78 | 302 | 313 | EITEAAVLLFYR |
Figure 2Complete amino acid sequence of omentin-1. Vertical lines represent possible tryptic digestion points and underlined peptides are the ones detected by MALDI-TOF/TOF analysis.
Figure 3(a) Western blot analysis of the pooled PF samples from ECS patients and PE samples from IP patients. The 4th fraction after MicroRotofor fractionation was pooled and used for analysis. (b) Graphical presentation of the band intensities measured with ImageJ.